The MedicX Fund Limited Scrip Calculation Price for March 2017 Dividend (7206X)
24 February 2017 - 2:43AM
UK Regulatory
TIDMMXF
RNS Number : 7206X
The MedicX Fund Limited
23 February 2017
For immediate release
23 February 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Scrip Calculation Price for the March 2017 Dividend in relation
to the Scrip Dividend Scheme
On 17 May 2010 the Board of MedicX Fund Limited announced an
opportunity for qualifying Shareholders to receive relevant
dividends in new ordinary shares instead of in cash (the
"Scheme").
In relation to the dividend for the period 1 October 2016 to 31
December 2016 payable on 31 March 2017 (the "March 2017 Dividend"),
the price of a new ordinary share in relation to the Scrip Dividend
Scheme (the "Scrip Calculation Price") has been set at 88.05 pence.
This is the average of the closing middle market quotations for the
Company's ordinary shares for the five consecutive business days
commencing on the Ex-Dividend date of 16 February 2017.
In order to be valid, Mandate forms must be received by the
Company's registrars, Capita Asset Services, (or CREST instructions
entered) by no later than 5.00 p.m. on 10 March 2017 (the "Mandate
Delivery Deadline") in order for elections under the Scrip Dividend
Scheme to be effective in relation to the March 2017 Dividend. The
Company mailed, on 21 February 2017, personalised Mandate Forms to
Shareholders new on the Register since 18 November 2016 and before
17 February 2017 (the "Record Date"). Other Shareholders can use
their Mandate Forms issued for previous scrip dividends offered, or
obtain Mandate Forms from Capita Asset Services.
Mandate Forms remain valid for all Relevant Dividends where a
Scrip Dividend Alternative is offered, until cancelled. Therefore,
Shareholders who have previously completed a Mandate Form but no
longer wish to receive a Scrip Dividend should write to Capita
Asset Services, Corporate Actions, The Registry, 34 Beckenham Road,
Beckenham, Kent, BR3 4TU, by no later than 5.00 p.m. on the Mandate
Delivery Deadline for the Relevant Dividend to inform them that
they wish to revoke the election and receive a cash dividend.
Shareholders who do not wish to receive a Scrip Dividend
Alternative and have not previously completed a Mandate Form need
take no further action and will receive a cash dividend in respect
of the March 2017 Dividend in the usual way. The payment date in
respect of the March 2017 Dividend is 31 March 2017.
Shareholders who have any questions regarding the Scrip Dividend
Scheme should contact the Capita Asset Services helpline on 0371
664 0321*.
*Calls made to this number are charged at 10 pence per minute
plus network charges. Lines are open 8.30 a.m. to 5.30 p.m. (London
time) Monday to Friday (except Bank Holidays).
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Victoria Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or
together with its subsidiaries, the "Group") is the specialist
primary care infrastructure investor in modern, purpose-built
primary healthcare properties in the United Kingdom and Ireland,
listed on the London Stock Exchange, with a portfolio comprising
152 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP6 billion of funds for more than 50,000 retail and institutional
investors. Octopus Healthcare Adviser Ltd is authorised and
regulated by the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBUGDDCXDBGRX
(END) Dow Jones Newswires
February 23, 2017 10:43 ET (15:43 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024